Omeprazole is generally safe for short courses of 4 to 8 weeks, but long-term use carries real, measurable risks that increase with time. For most people, it was never meant to be a permanent medication. Standard treatment guidelines recommend 8 weeks or less for typical acid reflux, with indefinite use reserved for a handful of serious conditions. If you’ve been taking omeprazole for months or years without a clear medical reason to continue, the risk-benefit balance shifts in ways worth understanding.
When Long-Term Use Is Medically Necessary
There are specific conditions where staying on omeprazole indefinitely is the right call. The American Gastroenterological Association recommends against discontinuing proton pump inhibitors (PPIs) like omeprazole in patients with Barrett’s esophagus, eosinophilic esophagitis, or idiopathic pulmonary fibrosis. People with complicated reflux disease, including a history of severe erosive esophagitis, esophageal ulcers, or narrowing of the esophagus from scar tissue, also generally need to stay on long-term therapy.
The American College of Gastroenterology recommends indefinite maintenance therapy for people with grade C or D esophagitis, the more severe forms of inflammation in the esophagus. For everyone else, the intended duration is 8 weeks or less, after which you and your provider should reassess whether you still need it.
Bone Fracture Risk
One of the most consistent findings in the research is a link between long-term PPI use and broken bones. A meta-analysis of 11 studies found that older adults on PPIs had a 41% increased risk of fractures compared to non-users. The risk isn’t limited to one type of fracture: hip fracture risk rises by roughly 20 to 42%, and spinal fracture risk by 50 to 56%.
The effect is more pronounced in older adults than in younger populations, where the overall fracture risk increase is closer to 16 to 20%. The mechanism likely involves reduced calcium absorption, since stomach acid plays a role in breaking down and absorbing calcium from food. If you’re over 60 and have been on omeprazole for years, this is one of the more important risks to weigh.
Kidney Function
The connection between omeprazole and kidney problems has become clearer over the past decade. PPIs were initially linked to a specific type of kidney inflammation called acute interstitial nephritis, a condition where the kidneys swell and lose function suddenly. But more recent research shows that kidney damage from omeprazole doesn’t require these acute flare-ups. Chronic kidney disease can develop gradually in long-term users even without a prior acute episode.
One study tracking chronic kidney disease patients found that 42.7% were omeprazole users, and those users were far more likely to see their kidney function worsen. Among omeprazole users, 70.6% experienced progression to worse stages of kidney disease, compared to just 10.5% of non-users. The hazard ratio was 7.34, meaning omeprazole users had roughly seven times the risk of their kidney disease getting worse. This is a striking number, though it comes from a population already dealing with kidney problems, so the risk for someone with healthy kidneys would be lower. Still, it underscores why periodic kidney function checks make sense for long-term users.
Nutrient Absorption
Stomach acid does more than digest food. It helps your body absorb several key nutrients, and suppressing it for months or years can create deficiencies. The nutrients most commonly discussed are vitamin B12, magnesium, calcium, and iron.
The real-world evidence on these deficiencies is more nuanced than the warnings suggest. One primary care study comparing long-term PPI users to non-users found no significant differences in magnesium levels and actually found no cases of vitamin B12 deficiency in the PPI group (compared to 11% in the control group). This doesn’t mean deficiencies can’t happen, but it suggests they may be less common than feared, particularly in people who eat a varied diet. The FDA has nonetheless issued warnings about the risk of low magnesium with prolonged PPI use, because when it does occur, the consequences (muscle spasms, irregular heartbeat, seizures) can be serious.
Infection Risk
Stomach acid serves as a natural barrier against harmful bacteria. When you suppress it, certain infections become slightly more likely. The most discussed is Clostridioides difficile, a bacteria that causes severe diarrhea and colon inflammation, particularly in older adults and hospitalized patients. Canadian drug safety labels already note that PPI users are slightly more likely to develop this infection, though Health Canada has stated the evidence isn’t strong enough to confirm PPIs directly cause it.
Community-acquired pneumonia has also been studied as a potential risk, with the theory being that bacteria from the stomach can more easily travel to the lungs when acid levels are lower. The association appears strongest in the first few weeks of starting a PPI and fades somewhat over time.
What to Do If You’ve Been on It for Years
If you’ve been taking omeprazole for more than 8 weeks and don’t have one of the conditions that requires indefinite therapy, it’s worth having a conversation about stepping down. This doesn’t mean stopping abruptly. Quitting a PPI cold turkey often triggers rebound acid production, where your stomach temporarily makes even more acid than it did before you started the medication. This rebound effect can last a few weeks and often convinces people they still need the drug when they actually don’t.
A gradual taper works better. Common approaches include cutting the dose in half for a few weeks, then switching to every-other-day dosing before stopping. Some people transition to a less potent acid reducer during the taper. Lifestyle changes like elevating the head of your bed, avoiding meals within three hours of lying down, and identifying trigger foods can also reduce the need for daily acid suppression.
For people who do need to stay on omeprazole long-term, using the lowest effective dose matters. If 20 mg controls your symptoms as well as 40 mg, the lower dose reduces your exposure to the risks described above. Periodic blood work to check kidney function, magnesium, and vitamin B12 levels is reasonable for anyone who has been on the medication for a year or more, even though formal screening guidelines haven’t been standardized.